This is the second auditor change in 14 months for a $3M market-cap company with a going-concern warning, material weaknesses, and a prior-period restatement. The pattern strongly suggests the company is struggling to find a Big 4 or regional firm willing to sign off on its financials. Monitor for a potential Nasdaq delisting notice, further insider selling, or a going-concern restatement. The warrants (CDTTW) are likely to be severely impacted if the common stock faces delisting.
Price Chart
Executive Summary
CDT Equity Inc. dismissed its auditor CBIZ CPAs and engaged Carr, Riggs & Ingram (CRI) as its new independent registered public accounting firm. This is the second auditor change in just over a year (Marcum LLP was dismissed in April 2025), and the prior audit report contained a going-concern explanatory paragraph along with multiple material weaknesses in internal controls, including a prior-period restatement. The rapid auditor churn, going-concern doubt, and material weaknesses are significant red flags for a micro-cap pharmaceutical company.
Key Facts
- CDT dismissed CBIZ CPAs and engaged Carr, Riggs & Ingram (CRI) as its new auditor on June 23, 2026.
- This is the second auditor change in 14 months — Marcum LLP was dismissed in April 2025 and replaced by CBIZ CPAs.
- The prior audit report (FY 2025) contained a going-concern explanatory paragraph expressing substantial doubt about CDT's ability to continue as a going concern.
- Multiple material weaknesses in internal controls were disclosed, including: limited segregation of duties, lack of formal review/approval processes, recurring errors in account balances, failure to properly evaluate material transactions leading to a prior-period restatement, and inconsistent review of related-party transactions.
- The company has a market cap of only $3M and insiders sold $2.9M worth of stock in the last 30 days — a massive amount relative to market cap.
- Former auditor CBIZ CPAs agreed with the company's statements in the filing, confirming no disagreements but acknowledging the going-concern and material weakness disclosures.
Financial Impact
No financial figures provided in the filing. The company has a $3M market cap and insiders sold $2.9M in the last 30 days — nearly the entire market cap.
Risk Factors
- Going-concern risk — the prior audit report expressed substantial doubt about the company's ability to continue as a going concern.
- Auditor churn — this is the second auditor change in 14 months, suggesting difficulty retaining a qualified accounting firm.
- Material weaknesses in internal controls, including a prior-period restatement, increase the risk of further accounting errors or restatements.
- Insider selling of $2.9M in the last 30 days against a $3M market cap suggests informed selling ahead of potential bad news.
- Nasdaq delisting risk — the company's $3M market cap and repeated accounting issues could trigger non-compliance with listing standards.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-031093 |
| Exhibit: ex16-1.htm | 0001493152-26-031093 |
| Document: 0001493152-26-031093-index-headers.html | 0001493152-26-031093 |
| Document: 0001493152-26-031093-index.html | 0001493152-26-031093 |
| Document: 0001493152-26-031093.txt | 0001493152-26-031093 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 1, 2026 4w ago | 8-K | $37.00 $1.40 | ▲ +96.23% | ▲ +97.41% | $1.25 (+96.62%) |
Jul 31, 2026 9w ago | 8-K | $2.87 $1.68 | ▲ +41.36% | ▲ +42.60% | $1.25 (+56.37%) |
Jul 16, 2026 11w ago | 8-K | $0.3550 $3.15 | ▼ −785.92% | ▼ −782.30% | $1.25 (−252.11%) |
Jun 29, 2026 13w ago | 8-K | $0.5600 $2.85 | ▼ −408.04% | ▼ −409.06% | $1.25 (−123.21%) |
Jun 16, 2026 15w ago | 8-K | $0.6930 $0.3550 | ▲ +48.77% | ▲ +50.09% | $1.25 (−80.38%) |
May 6, 2026 21w ago | Press Release | $2.26 $0.8050 | ▼ −64.38% | ▼ −67.16% | $1.25 (−44.69%) |
Mar 4, 2026 30w ago | Press Release | $17.70 $5.10 | ▼ −71.19% | ▼ −66.77% | $1.25 (−92.94%) |
Feb 24, 2026 31w ago | 8-K | $17.25 $10.88 | ▼ −36.96% | ▼ −31.72% | $1.25 (−92.75%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access